Streetbeat News

Earnings

DOYU

DouYu Intl Hldgs shares are trading lower following the announcement of their Q4 results.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:13 am

BRAG

Bragg Gaming has updated its 2024 full year revenue and Adjusted EBITDA guidance, expecting revenue to increase by 9.1% to 16.6% to USD 109.7-117.2 million and Adjusted EBITDA to rise up to 21.7% to USD 16.3-19.9 million. These projections represent a midpoint growth of 12.8% for revenue and 10.9% for Adjusted EBITDA over 2023 figures.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:11 am

DIA

GLD

QQQ

SPY

U.S. stock markets closed lower, with the Dow Jones, S&P 500, and Nasdaq all recording declines. Asian markets were mixed, with gains in Japan and China but losses in Australia and India. European markets were up, with increases in the STOXX 50, DAX, and CAC. Gold hit a record high, while U.S. futures indicated a positive opening. Economic data showed a slight increase in the Chicago Fed National Activity Index and a drop in new home sales.

Portfolio Pulse from Akanksha Bakshi

March 26, 2024 | 11:11 am

CGTX

Cognition Therapeutics reported a FY23 net loss per share of $(0.86), an improvement from $(0.91) YoY. As of December 31, 2023, their cash and equivalents stood at approximately $29.9M.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:10 am

DADA

Dada Nexus shares are trading lower following the company's report of Q4 earnings per share (EPS) and revenues that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:10 am

BLUE

Bluebird Bio, Inc. (BLUE) announced it will restate its financial statements for 2022 and the first three quarters of both 2022 and 2023 due to issues related to the identification of embedded leases and the treatment of non-lease components in agreements with contract manufacturers. This restatement will be reflected in its Form 10K for 2023.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:09 am

ABOS

Acumen Pharmaceuticals reported a fiscal year 2023 earnings per share (EPS) of $(1.08), a slight decrease from the previous year's $(1.06). The company also reported having $306.1 million in cash, cash equivalents, and marketable securities.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:08 am

SOAR

Volato Group (AMEX:SOAR) reported a decrease in Q4 sales to $31.46M from $35.91M YoY and a significant increase in net loss to $(23.6)M from $(3.1)M YoY.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:06 am

BLUE

bluebird bio (NASDAQ:BLUE) reported Q4 sales of $7.80 million, missing the consensus estimate of $16.68 million by 53.24%. However, this represents a 7.70K% increase from the same period last year, where sales were $100.00 thousand.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:06 am

BRAG

Bragg Gaming Group (NASDAQ:BRAG) reported Q4 sales of $25.20M, missing the $37.82M estimate by 33.37%, and marking a 1.18% decrease from the same period last year. The company also reported an operating loss of $(0.4)M.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:04 am